Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling

An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer

(2013) Jinping Jia et al.   BMC Medical Genomics

Positive ALDH1A3 and Negative GPX3 Expressions Are Biomarkers for Poor Prognosis of Gallbladder Cancer

(2013) Zhu-lin Yang et al.   DISEASE MARKERS

HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome

(2013) J Wardwell-Ozgo et al.   ONCOGENE

MUC4 Overexpression Augments Cell Migration and Metastasis through EGFR Family Proteins in Triple Negative Breast Cancer Cells

(2013) Partha Mukhopadhyay et al.   PLoS One

Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3

(2013) P. Mao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Density-dependent lineage instability of MDA-MB-435 breast cancer cells

(2013) ANDREAS G. NERLICH et al.   Oncology Letters

Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP− primary glioblastoma

(2012) Wei Zhang et al.   CANCER LETTERS

HOX gene methylation status analysis in patients with hereditary breast cancer

(2012) Brunella Pilato et al.   JOURNAL OF HUMAN GENETICS

Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome

(2012) Xiao Li et al.   Journal of Thoracic Oncology

ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets

(2012) Yuchun Luo et al.   STEM CELLS

Association of FABP5 Expression With Poor Survival in Triple-Negative Breast Cancer

(2011) Rong-Zong Liu et al.   AMERICAN JOURNAL OF PATHOLOGY

Retinoids, Retinoic Acid Receptors, and Cancer

(2011) Xiao-Han Tang et al.   Annual Review of Pathology-Mechanisms of Disease

Genome-widein SilicoIdentification of New Conserved and Functional Retinoic Acid Receptor Response Elements (Direct Repeats Separated by 5 bp)

(2011) Sébastien Lalevée et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes

(2011) So Yeon Park et al.   MODERN PATHOLOGY

Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity and outcome to neoadjuvant chemotherapy

(2011) Thaer Khoury et al.   MODERN PATHOLOGY

Mucins in human neoplasms: Clinical pathology, gene expression and diagnostic application

(2011) Suguru Yonezawa et al.   PATHOLOGY INTERNATIONAL

DNA methylation profile during multistage progression of pulmonary adenocarcinomas

(2011) Jin-Haeng Chung et al.   VIRCHOWS ARCHIV

In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis

(2010) Veronique Neumeister et al.   AMERICAN JOURNAL OF PATHOLOGY

Retinoid signaling regulates breast cancer stem cell differentiation

(2010) Christophe Ginestier et al.   CELL CYCLE

A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer

(2010) Margarette Bryan et al.   INVESTIGATIONAL NEW DRUGS

Retinoids regulate stem cell differentiation

(2010) Lorraine J. Gudas et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma

(2010) Yi Zhu et al.   MEDICAL ONCOLOGY

Stromal retinoic acid receptor   promotes mammary gland tumorigenesis

(2010) X. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis

(2010) Paola Marcato et al.   STEM CELLS

Kinetic characterization of recombinant mouse retinal dehydrogenase types 3 and 4 for retinal substrates

(2009) Aurelia Sima et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment

(2009) Erika Resetkova et al.   BREAST CANCER RESEARCH AND TREATMENT

Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?

(2009) A. Hollestelle et al.   CANCER RESEARCH

MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?

(2009) Ann F. Chambers   CANCER RESEARCH

Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression

(2009) Koji Morimoto et al.   CANCER SCIENCE

Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

(2009) E. Charafe-Jauffret et al.   CLINICAL CANCER RESEARCH

ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome

(2009) Ting Li et al.   LABORATORY INVESTIGATION

CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma

(2009) Baek-hui Kim et al.   VIRCHOWS ARCHIV

Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily

(2008) Satori A Marchitti et al.   Expert Opinion on Drug Metabolism & Toxicology

Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPAR /  to RAR

(2008) T. T. Schug et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior

(2008) Suguru Yonezawa et al.   PROTEOMICS

Structure, evolution, and biology of the MUC4 mucin

(2007) Pallavi Chaturvedi et al.   FASEB JOURNAL